Moreover, longitudinal SMRP measurements have corresponded well with tumor response and progression [68,69], and a 10% reduction in serum SMRP level was found to be associated with radiological response [70,71,72], confirming a role for serum SMRP monitoring in MPM patients who initially presented with an elevated SMRP level. The gene discussed is MSLN; the disease is neoplasm.